These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21275998)

  • 21. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.
    Ostrowski SR; Bochsen L; Windeløv NA; Salado-Jimena JA; Reynaerts I; Goodrich RP; Johansson PI
    Transfusion; 2011 Feb; 51(2):344-56. PubMed ID: 20723169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.
    Ostrowski SR; Bochsen L; Salado-Jimena JA; Ullum H; Reynaerts I; Goodrich RP; Johansson PI
    Transfusion; 2010 Oct; 50(10):2210-9. PubMed ID: 20456708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
    Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
    Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature.
    Moroff G; AuBuchon JP; Pickard C; Whitley PH; Heaton WA; Holme S
    Transfusion; 2011 Jan; 51 Suppl 1():7S-14S. PubMed ID: 21223290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a riboflavin and ultraviolet light-based device to treat whole blood.
    Reddy HL; Doane SK; Keil SD; Marschner S; Goodrich RP
    Transfusion; 2013 Jan; 53 Suppl 1():131S-136S. PubMed ID: 23301965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time measurement of platelet shape change by light scattering under riboflavin and ultraviolet light treatment.
    Terada C; Shiba M; Satake M; Tadokoro K
    Transfusion; 2016 Mar; 56(3):587-95. PubMed ID: 26536611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
    Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
    Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM; Steisel A; Gathof BS
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
    Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
    Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation.
    El Chaar M; Atwal S; Freimanis GL; Dinko B; Sutherland CJ; Allain JP
    Transfusion; 2013 Dec; 53(12):3174-83. PubMed ID: 23656538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model.
    Chi X; Zhi L; Vostal JG
    Transfusion; 2014 Jan; 54(1):74-85. PubMed ID: 23656563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.
    Okoye OT; Reddy H; Wong MD; Doane S; Resnick S; Karamanos E; Skiada D; Goodrich R; Inaba K
    Transfusion; 2015 Mar; 55(3):532-43. PubMed ID: 25582335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an in vitro biotinylation technique for determination of posttransfusion viability of stored canine packed red blood cells.
    Wardrop KJ; Tucker RL; Anderson EP
    Am J Vet Res; 1998 Apr; 59(4):397-400. PubMed ID: 9563619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultraviolet light and riboflavin accelerates red blood cell dysfunction in vitro and in a guinea pig transfusion model.
    Baek JH; Shin HKH; Xu F; Zhang X; Williams MC; Gao Y; Vostal JG; Buehler PW; Villa C; D'Agnillo F
    Blood Transfus; 2024 Jul; 22(4):316-327. PubMed ID: 38814883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
    Winter KM; Johnson L; Kwok M; Vidovic D; Hyland RA; Mufti N; Erickson A; Marks DC
    Transfusion; 2014 Jul; 54(7):1798-807. PubMed ID: 24617658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature.
    Lunde THF; Hartson L; Bailey SL; Hervig TA
    Transfusion; 2021 Jul; 61 Suppl 1():S101-S110. PubMed ID: 34269459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.